In Veritas Medical Diagnostics

In Veritas Medical Diagnostics (IVMD) was a medical technology firm focused on developing point-of-care (POC) diagnostic systems for chronic disease management. The company's flagship product was a handheld device designed to measure the International Normalized Ratio (INR), allowing patients on anticoagulant medication like warfarin to monitor their blood clotting time at home. Utilizing proprietary electrochemical biosensor technology, IVMD aimed to provide a more convenient and frequent testing alternative to traditional laboratory-based monitoring. The company's platform was designed to deliver lab-quality results within minutes, facilitating better management of conditions like atrial fibrillation and deep vein thrombosis. Following financial challenges, the company's assets and intellectual property were acquired by Lifeline Biotechnologies in 2012.